Welcome to our dedicated page for BrightSpring Health Services news (Ticker: BTSG), a resource for investors and traders seeking the latest updates and insights on BrightSpring Health Services stock.
BrightSpring Health Services reports news on its home- and community-based healthcare platform for complex populations, with recurring updates on Pharmacy Solutions and Provider Services. Company announcements commonly cover financial results, guidance, service-line performance, and care delivery across pharmacy, home health care, primary care, rehabilitation and behavioral health.
BrightSpring news also includes capital actions and corporate-structure developments, including secondary offerings of common stock, share repurchases, investor presentations, and completed portfolio changes such as the sale of ResCare Community Living. These updates frame the company around its continuing pharmacy and provider health solutions business.
BrightSpring Health Services (NASDAQ: BTSG) reported Q1 2026 continuing-operations results: Revenue $3,614M (+25.6% YoY), Gross profit $482M (+42.5% YoY), Net income $74M (vs. $9M) and Adjusted EBITDA $190M (+44.8% YoY). The Company closed the Community Living divestiture (gain $31.2M) and completed a secondary offering plus a $60.0M share repurchase. Management raised full-year 2026 guidance to $14,725M–$15,225M revenue and $795M–$825M Adjusted EBITDA, and reported pro forma leverage of 2.27x as of March 31, 2026.
BrightSpring Health Services (NASDAQ: BTSG) will release its first quarter 2026 financial results on May 1, 2026 before an earnings conference call.
The Company will hold a conference call at 8:30 a.m. ET the same day; registration is required to participate. A live and archived webcast plus presentation materials will be available on the investor relations site under Events & Presentations.
BrightSpring Health Services (NASDAQ: BTSG) completed the sale of ResCare Community Living to Sevita on March 31, 2026. The divestiture, first agreed in January 2025, transfers Community Living operations to Sevita while BrightSpring refocuses on its Provider Services division: Home Health Care, Personal Care and Rehab Therapy.
The companies said the transition prioritized continuity of care, regulatory continuity, and workforce stability, and Sevita expects to expand programming and services using combined strengths.
BrightSpring Health Services (NASDAQ: BTSG) priced a previously announced underwritten secondary offering of 20,000,000 shares at $41.15 per share, expected to close on March 4, 2026. No shares are being sold by the company; selling stockholders will receive all proceeds.
The company authorized a concurrent repurchase of 1,464,807 shares from the underwriter at the offering price; the repurchase is conditioned on and expected to close simultaneously with the offering. Goldman Sachs is sole book-running manager and the offering relies on an S-3 shelf registration filed June 10, 2025.
BrightSpring (NASDAQ: BTSG) announced on March 2, 2026 that certain stockholders intend to sell an aggregate of 20,000,000 shares in a secondary offering; BrightSpring will not sell any shares and Selling Stockholders will receive all proceeds.
The company authorized, subject to the offering's completion, a concurrent repurchase of up to the lesser of 10% of the shares sold or $60.0 million, at the offering price, with Goldman Sachs acting as sole book-running manager. A Form S-3 shelf registration became effective on June 10, 2025.
BrightSpring Health Services (NASDAQ: BTSG) reported strong fourth-quarter and full-year 2025 results and issued 2026 guidance. FY2025 revenue was $12,911M (+28.2%); Adjusted EBITDA was $618M (+34.2%); net income was $104.8M and operating cash flow was $490M. 2026 revenue guidance: $14,450M–$15,000M; Adjusted EBITDA guidance: $760M–$790M.
The company excluded the Community Living business from continuing operations and expects that divestiture to close by Q1 2026.
BrightSpring Health Services (NASDAQ: BTSG) will host an Investor Day on March 17, 2026, beginning at 8:30 a.m. ET. The event will include leadership presentations and multiple Q&A sessions for investors and analysts.
A live webcast and archived replay will be available on the company's investor relations site, with presentation materials posted under Events & Presentations. In-person attendance is limited and by invitation; interested institutional investors and analysts should contact the company by email.
BrightSpring Health Services (NASDAQ: BTSG) will release its fourth quarter and full year 2025 financial results on February 27, 2026, before an earnings conference call scheduled for 8:30 a.m. ET the same day. A live and archived webcast and related presentation materials will be available on the company investor relations website under Events & Presentations.
BrightSpring Health Services (NASDAQ: BTSG) reported strong third-quarter 2025 results and raised full-year revenue guidance. Q3 revenues were $3,334 million (up 28.2% YoY) with gross profit $392 million (up 21.3%). The company reported net income $37.5 million versus a net loss in Q3 2024 and Adjusted EBITDA $160 million (up 37.2% YoY).
BrightSpring increased 2025 revenue guidance to $12,500–$12,800 million and reiterated Adjusted EBITDA guidance of $605–$615 million. The company expects the planned divestiture of its Community Living business to Sevita to close in Q1 2026. A 15,000,000-share secondary by KKR and management closed Oct 22, 2025; BrightSpring repurchased 1,500,000 shares. Leverage stood at 3.31x at Sept 30, 2025.
BrightSpring Health Services (NASDAQ: BTSG) priced an underwritten secondary offering of 15,000,000 common shares by selling stockholders, with no shares issued by BrightSpring and proceeds paid to the sellers. The offering is expected to close on October 22, 2025, subject to customary conditions.
Subject to closing, BrightSpring authorized a concurrent repurchase of 1,500,000 of those shares from the underwriter at the same per-share price; the underwriter will not receive fees on the repurchased shares. BofA Securities is sole book-running manager. The offering will be made by prospectus supplement under the company’s Form S-3 shelf registration.